[{"NetIncomeLossConverted_3_Q3_USD":-18913000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":11991000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":11953000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":20976000.0,"EarningsPerShareDiluted_1_Q3_USD":0.04,"EarningsPerShareDiluted_3_Q3_USD":-1.58,"StockholdersEquity_0_Q3_USD":195100000.0,"RevenuesConverted_1_Q3_USD":52979000.0,"RevenuesConverted_3_Q3_USD":151223000.0,"Assets_0_Q3_USD":462581000.0,"NetIncomeLossConverted_1_Q3_USD":422000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":11953000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":12003000.0,"EarningsPerShareBasic_1_Q3_USD":0.04,"EarningsPerShareBasic_3_Q3_USD":-1.58,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]